CD57 Antibody, anti-human, Vio® B515, REAdye_lease™, 200 µL
文献支持

CD57 Antibody, anti-human, Vio

® B515, REAdye_lease™, 200 µL
收藏
  • 询价
  • Miltenyi Biotec已认证
  • 德国
  • 130-131-843
  • 2025年12月09日
  • MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
  • cell line
  • human
avatar
品牌商
13钻石会员
  • 企业认证

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      CD57

    • 形态

      Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.

    • 保存条件

      避光,4-8℃

    • 克隆性

      REAL352

    • 标记物

      Vio B515

    • 适应物种

      human

    • 保质期

      24个月

    • 供应商

      Miltenyi biotec

    • 宿主

      cell line

    • 应用范围

      MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry

    • 抗体英文名

      CD57 Antibody, anti-human, REAdye_lease™

    • 抗体名

      CD57 Antibody, anti-human, REAdye_lease™

    • 规格

      200 µL

    Detection of CD57+ cellsClone REAL352 is an antibody fragment derived from the full CD57 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity. | Clone REAL352 recognizes the human CD57 antigen. CD57, also known as HNK-1 or Leu-7, is an antigenic oligosaccharide moiety detected on extracellular proteins of certain cell types. In blood, CD57 is found on 15–20% of mononuclear cells, including subsets of NK and T cells, but not on erythrocytes, monocytes, granulocytes, or platelets. CD57 expression can be also found on a variety of neural cell types. CD57 has been shown to be expressed on late stage effector CD8+ T cells. The frequency of CD57+ T lymphocytes is raised in a variety of diseases. CD57 expression is also increased on chronically activated CD8+ T cells in persistent viral infections, such as HIV. CD57 is a helpful marker to differentiate between Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) and T-cell/histiocyte-rich B-cell lymphoma (T/HRBCL). | For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675).

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Brenchley, J. M. et al. (2003) Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101: 2711–2720. | Boudová, L. et al. (2003) Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood 102 (10): 3753–3758. | Muntasell, A. et al. (2019) High Numbers of Circulating CD57(+) NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2(+) Primary Breast Cancer. Cancer Immunol Res. 7 (8): 1280–1292. | Lian, J. et al. (2020) Immunosenescence: a key player in cancer development. J Hematol Oncol. 13 (1): 151.
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    德国美天旎生物技术有限公司
    2025年12月09日询价
    ¥500
    北京百奥创新科技有限公司
    2025年05月30日询价
    ¥1650
    武汉菲恩生物科技有限公司
    2025年11月11日询价
    询价
    上海联迈生物工程有限公司
    2025年03月19日询价
    文献支持
    CD57 Antibody, anti-human, Vio® B515, REAdye_lease™, 200 µL
    询价